Ex Parte NEERVEN - Page 7

                 Appeal 2007-1070                                                                                      
                 Application 09/467,901                                                                                

                                                        Frank                                                          
                 10.  Frank describes “a method to detect canine IgE using a canine Fc                                 
                 epsilon receptor (FcεR) to detect canine IgE antibodies in a biological                               
                 sample from a canid” (Frank, Abstract).                                                               
                 11.  Frank states:                                                                                    
                        The present invention relates to the discovery that purified high                              
                        affinity canine Fc epsilon receptor (i.e., FcεRI; referred to                                  
                        herein as FcεR) can be used in canine epsilon immunoglobulin                                   
                        (referred to herein as IgE or IgE antibody)-based detection (e.g.,                             
                        diagnostic, screening) methods and kits.                                                       
                 (Frank, col. 2, ll. 13-17.)                                                                           
                 12.  Frank describes the advantage of using FcεR in an IgE detection assay                            
                 instead of anti-IgE.                                                                                  
                        [A]ntibodies that bind selectively to . . . (i.e., anti-IgE                                    
                        antibodies) . . . have been used to detect IgE. These anti-IgE                                 
                        antibodies, however, can cross-react with other antibody                                       
                        idiotypes . . . . The discovery of the present invention includes                              
                        the use of . . . (FcεR) . . . to detect the presence of IgE in a                               
                        putative IgE-containing composition. . . . A canine FcεR                                       
                        molecule provides an advantage over, for example anti-IgE                                      
                        antibodies, to detect IgE because a canine FcεR molecule . . .                                 
                        can bind to a canine IgE with more specificity . . . and more                                  
                        sensitivity . . . than anti-IgE binding antibodies.                                            
                 (Frank, col. 1, ll. 24-41.)                                                                           
                 13.                                                                                                   
                        The  use  of  canine  FcεR  in  diagnostic  methods  and  kits  is                             
                        unexpected because the use of canine FcεR avoids                                               
                        complications presented by use of antibodies that bind to IgE                                  
                        (i.e.,  anti-IgE  antibodies).    Such  complications  include,  for                           
                        example, non-specific binding of anti-IgE antibodies to other                                  
                        classes  of  immunoglobulin  such  as  gamma  immunoglobulin                                   
                        (i.e., IgG).                                                                                   

                                                          7                                                            

Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  13  14  Next

Last modified: September 9, 2013